Results 91 to 100 of about 88,666 (249)

Classification of Myelodysplastic, Myeloproliferative, and Myelodysplastic/Myeloproliferative Neoplasms: The Past, Present, and Future

open access: yesAmerican Journal of Hematology, Volume 100, Issue S4, Page 5-15, June 2025.
ABSTRACT With the recent publication of new classification systems of hematopoietic neoplasms, understanding how recognition of disease entities has occurred over time and the subsequent development of formal disease classifications is of importance. This review focuses on the early recognition of myeloid disorders, especially chronic myeloid disorders,
Daniel A. Arber, Attilio Orazi
wiley   +1 more source

Permanent Sensorineural Deafness in a Patient with Chronic Myelogenous Leukemia Secondary to Intracranial Hemorrhage

open access: yesCase Reports in Hematology, 2013
A 52-year-old male presented with tinnitus and fullness in left ear for one day. Workup revealed a white blood cell count of 685×103/μL with marked increase in granulocyte series and myeloid precursors on peripheral smear.
Sakshi Kapur   +3 more
doaj   +1 more source

An uneventful pregnancy and delivery, in a case with chronic myeloid leukemia on imatinib

open access: yesIndian Journal of Medical and Paediatric Oncology, 2011
The concomitant occurrence of pregnancy and chronic myelogenous leukemia is uncommon. We describe the successful management of a 24-year-old woman in the first trimester of her pregnancy with chronic myelogenous leukemia (CML) in the chronic phase, who ...
Jovita Martin   +4 more
doaj   +1 more source

The detection and classification of blast cell in Leukaemia Acute Promyelocytic Leukaemia (AML M3) blood using simulated annealing and neural networks [PDF]

open access: yes, 2011
This paper was delivered at AIME 2011: 13th Conference on Artifical Intelligence in Medicine.This paper presents a method for the detection and classification of blast cells in M3 with others sub-types using simulated annealing and neural networks.
Hassan, R, Ismail, W, Payne, A, Swift, S
core  

Label‐Free Microscale Technologies for Isolation of Heterogeneous Circulating Tumor Cells

open access: yesAdvanced NanoBiomed Research, Volume 5, Issue 6, June 2025.
The isolation of circulating tumor cells (CTCs) from liquid biopsy samples is crucial for cancer treatment and monitoring. This review evaluates primary label‐free isolation methods for capturing heterogeneous CTCs and examines their potential to provide deeper insights into tumor heterogeneity and dynamics of cancer progression.
Gürhan Özkayar   +5 more
wiley   +1 more source

Applications of Microarray Technology to Acute Myelogenous Leukemia

open access: yesCancer Informatics, 2009
Microarray technology is a powerful tool, which has been applied to further the understanding of gene expression changes in disease. Array technology has been applied to the diagnosis and prognosis of Acute Myelogenous Leukemia (AML).
Rashmi S. Goswami   +4 more
doaj   +2 more sources

Acute Myelogenous Leukemia With Trisomy 8 and Concomitant Acquired Factor VII Deficiency

open access: yesJournal of Investigative Medicine High Impact Case Reports, 2019
Acquired isolated factor VII deficiency is a rare bleeding disorder and has been reported in 31 cases. This is in contrast to congenital factor VII deficiency, which while also infrequent is the most common rare congenital bleeding disorder.
Leila Moosavi MD   +4 more
doaj   +1 more source

A patient with maculopapular rash and lichenoid skin damage caused by ponatinib

open access: yesJournal of International Medical Research, 2020
Tyrosine kinase inhibitors (TKIs) are invaluable for the treatment of patients with chronic myelogenous leukemia. Although TKIs are generally better tolerated than traditional chemotherapy, dermatologic side effects are common and present a significant ...
Ingrid Anna Teigen   +2 more
doaj   +1 more source

"HLA Class II Allele and Haplotype Frequencies in Iranian Patients with Acute Myelogenous Leukemia and Control Group "

open access: yesIranian Journal of Allergy, Asthma and Immunology, 2006
Previous studies have demonstrated some significant differences in HLA allele frequencies in leukemic patients and normal subjects. We have analyzed HLA class II alleles and haplotypes in 60 Iranian patients with acute myelogenous leukemia (AML) and 180
Abdolfattah Sarafnejad   +7 more
doaj  

Home - About - Disclaimer - Privacy